Financial Highlights for Q1 FY27

Comparative Financial Performance (Amounts in INR Lakhs):

  • Total Revenue: ₹6,002 (Q1 FY27) vs ₹4,673 (Q1 FY26) - increase of 28% YoY
  • EBIDTA: ₹605 (Q1 FY27) vs ₹294 (Q1 FY26) - increase of 106% YoY
  • EBITDA Margin: 10.1% (Q1 FY27) vs 6.3% (Q1 FY26) - expansion of 380 basis points
  • PAT: ₹34 (Q1 FY27) vs -₹22 (Q1 FY26) - not comparable due to exceptional items
  • Cash PAT (PAT + Depreciation): ₹477 (Q1 FY27) vs ₹355 (Q1 FY26) - increase of 34% YoY

Note: PAT and Cash PAT include exceptional item loss from damage due to a fire incident in Ghaziabad. All figures are pre-Ind AS.

Key Operating Metrics for Q1 FY27

Comparative Operating Performance:

  • ATP (Average Ticket Price): ₹236 (Q1 FY27) vs ₹232 (Q1 FY26) - increase of 2% YoY
  • SPH (Spend Per Head): ₹108 (Q1 FY27) vs ₹108 (Q1 FY26) - no change
  • ATP + SPH: ₹345 (Q1 FY27) vs ₹340 (Q1 FY26) - increase of 1% YoY
  • Admissions: 18.0 lakh (Q1 FY27) vs 13.9 lakh (Q1 FY26) - increase of 29% YoY
  • Net Box Office Collections: ₹3,615 lakh (Q1 FY27) vs ₹2,748 lakh (Q1 FY26) - increase of 32% YoY
  • Net F&B Collections: ₹1,856 lakh (Q1 FY27) vs ₹1,433 lakh (Q1 FY26) - increase of 29% YoY

Current Operational Footprint:

  • Operational Cinemas: 22
  • Operational Screens: 85
  • Cities Present In: 15
  • Seats: 21,100+

Strategic Priorities

The company outlined three key strategic priorities to drive growth:

1. Expansion in Southern Region: Building a diversified national footprint by entering high-potential southern cities to leverage premium MovieMAX experience and localized content strategy, improving portfolio diversification and access to year-round regional blockbusters.

2. Compelling Cinema Queue: Expecting a broader slate of Hindi, Hollywood and regional releases to sustain audience engagement and improve occupancy levels throughout the year.

3. Asset-Light O&M Model: Accelerating growth through Operations & Management model, partnering with developers to launch multiplexes without significant capital investment, thereby improving return ratios and preserving balance sheet flexibility.

Management Commentary

Mr. Ashish Kanakia, CEO of Cineline India Limited, commented on the performance:

Q1 FY27 reflected strong operational and financial performance owing to continued momentum from films including "Dhurandar: The Revenge," "Raja Shivaji," "Welcome to the Jungle," and "Bhoot Bangla" that supported footfalls and higher Box Office Collections.

The company remains on track to add 20-25 screens in FY27, with the launch of three new screens in Gurgaon scheduled for Q2 FY27. The strong presence across Western India continued to benefit from robust performance of regional content.

As part of long-term growth strategy, Cineline is expanding into South India to establish presence in one of India's most resilient cinema markets and capitalize on underpenetrated regions with strong demand potential. Expansion will be pursued in a disciplined and capital-efficient manner.

Supported by continued premiumization and improving consumer spending, the company reported ATP of ₹236 and SPH of ₹108 during the quarter.

Forward-Looking Content Pipeline

The content pipeline remains encouraging with strong lineup of:

  • Bollywood releases: Ramayana: Part 1, King, Toxic, and Vann – Force of the Forest
  • Hollywood titles: The Odyssey, Spider-Man: Brand New Day, and Avengers: Doomsday

The company expects diverse slate across languages and genres to support sustained audience engagement and drive theatrical footfalls.

Company Overview

MovieMax Cinemas, a part of the Kanakia Group, is a rapidly expanding chain of cinemas operated by Cineline India Limited which made a comeback in 2022. The company portfolio includes 85 operational screens across 22 properties in 7 states and 1 Union Territory. The company offers spacious auditoriums with plush seating, varied F&B offerings, and movies ranging from all Indian languages to Hollywood and world cinema.

Safe Harbor Statement

The document contains forward-looking statements based on estimates and anticipated effects of future events, subject to numerous risks and uncertainties that may cause actual results to differ materially from those anticipated. The company assumes no obligation to update forward-looking statements.